ARTICLE | Company News
Chinese Academy of Sciences, MicroConstants China deal
February 9, 2015 8:00 AM UTC
MicroConstants received worldwide rights from the academy’s Institute of Biophysics to develop and commercialize antibody AA98 to treat cancer, multiple sclerosis (MS) and age-related macular degener...